Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

133
Delayed Quote. Delayed London Stock Exchange - 09/01 11:35:01 am
1460 GBp   -0.98%
10h ago CIPLA : launches copy of GSK's top asthma drug in Germany, Sweden
3d ago GLAXOSMITHKLINE : Assigned Patent
4d ago GLAXOSMITHKLINE : Ebola vaccine trials fast-tracked by international consor..
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
GlaxoSmithKline plc : Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201120122013201420152016
Sales27 38726 43126 50523 68924 91625 757
Operating income (EBITDA)10 2319 4158 8837 9628 3228 735
Operating profit (EBIT)8 5548 3308 0156 6276 9427 360
Pre-Tax Profit (EBT)7 6986 6926 6475 1515 6256 244
Net income5 2614 5655 6283 9334 1004 712
EPS (PNC)10391,511178,397,795,4
Dividend per Share (PNC)70,074,078,080,883,187,7
Yield4,75%5,02%5,29%5,48%5,63%5,95%
Announcement Date02/07/2012
12:00pm
02/06/2013
12:01pm
02/05/2014
12:00pm
---
Finances - Leverage
GlaxoSmithKline plc : Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201120122013201420152016
Debt9 00314 03712 64512 71110 63011 158
Finance------
Operating income (EBITDA)10 2319 4158 8837 9628 3228 735
Leverage
(Debt/EBITDA)
0,88x1,49x1,42x1,60x1,28x1,28x
Capital Expenditure9231 0511 1881 3931 7791 412
Book Value Per Share (BVPS)162 PNC120 PNC146 PNC142 PNC129 PNC141 PNC
Cash Flow per Share124 PNC87,7 PNC149 PNC111 PNC125 PNC148 PNC
Announcement Date02/07/2012
12:00pm
02/06/2013
12:01pm
02/05/2014
12:00pm
---
Balance Sheet Analysis
GlaxoSmithKline plc : Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 71 506 M GBP -
Entreprise Value (EV) 84 217 M GBP 82 136 M GBP
Valuation 2014e 2015e
PER (Price / EPS) 18,8x 15,1x
Capitalization / Revenue 3,02x 2,87x
EV / Revenue 3,56x 3,30x
EV / EBITDA 10,6x 9,87x
Yield (DPS / Price) 5,48% 5,63%
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 28,0% 27,9%
operating Leverage (Delta EBIT / Delta Sales) -1,63x 0,92x
Net Margin (Net Profit / Revenue) 16,6% 16,5%
ROA (Net Profit / Asset) 7,90% 7,90%
ROE (Net Profit / Equities) 63,5% 69,3%
Rate of Dividend 103% 85,1%
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   5,88% 7,14%
Cash Flow / Sales (Taux d'autofinancement) 22,7% 24,3%
Capital Intensity (Assets / Sales) 2,10x 2,08x
Financial Leverage (Net Debt / EBITDA) 1,60x 1,28x
Price Earning Ratio
GlaxoSmithKline plc : Price Earning Ratio
EPS & Dividend
GlaxoSmithKline plc : EPS Dividend
Dynamic quotes  
ON
| OFF